Carregant...
Liver Bid-suppression for treatment of fibrosis associated with nonalcoholic steatohepatitis
BACKGROUND & AIMS: Liver fibrosis is the most worrisome feature of Nonalcoholic Steatohepatitis (NASH). Growing evidence supports a link between hepatocyte apoptosis and liver fibrogenesis. Our aim was to determine the therapeutic efficacy and safety of liver Bid, a key pro-apoptotic molecule, s...
Guardat en:
| Publicat a: | J Hepatol |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4761314/ https://ncbi.nlm.nih.gov/pubmed/26555271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2015.11.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|